Metropolis Healthcare Limited Stock: price and insider trades · India
No insider purchase over the last 90 days. The latest, by SUSHIL SHAH, was filed 21 Feb 2022.
Metropolis Healthcare Limited: what insiders have been doing
Metropolis Healthcare Limited belongs to the Health Care sector. Filings by its managers are published through SEBI (PIT + SAST). Over the twelve months to 26 October 2026, 4 filings were filed, from 4 insiders.
There is no open-market purchase to report; the filings show 4 sales worth €10.8M by 4 insiders. No amount is published for 2 filings, which the totals therefore leave out. One trade stands out by size: a sale of €5.4M from Duru Shah Family Trust, disclosed on 13 August 2026, or 0.49% of market capitalisation.
Half of the filings or more reach the SEBI (PIT + SAST) feed on the day of the trade. That lag is the time during which only the insider knows about the trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives.
Compared with its exchange (1,891 companies, median 4 filings), a count of 4 filings is typical. Since 2021, the database holds 4 purchases and 33 sales by insiders of the company.
Other companies in the same sector with recent insider buying flagged by our signals: Dynavox Group AB and EssilorLuxottica. Every figure here comes from the filings published by SEBI (PIT + SAST) and describes the past, not future prices; it is not investment advice.
Who traded when
BuySaleSince the insiders bought
- -33.7%Entry ₹508.33 · Close at T+365 ₹337.15
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Metropolis Healthcare Limited Buy (bullish), based on 19 analysts. Average price target: ₹666.05.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
- 1,050,000 shares-MarketSEBI:883c096fc72feeddee72dd210965b2d3fb785ed1
- 1,050,000 shares-MarketSEBI:1096ad6b009bace9ab7aea2c81505aae5070a64a
- 1,050,000 shares@ ₹564.000.49% mcap100.0% of flowEquityMarket SaleSEBI:10faebe54d203445b4a890b71011b7de42e6d373
- 1,050,000 shares@ ₹564.000.49% mcap100.0% of flowEquityMarket SaleSEBI:a543d89e4f342d28b49f580fcab0fc381ab80cd0
- 1,167,058 sharesEquity SharesSEBI:fccbf34c3bb5f6456d490b5397c446a4c4b3afa9
- 1,167,058 sharesEquity SharesSEBI:1ce0e41b38f3291f1f8f32e11ed81f4e2c0f67d9
- 765,659 sharesEquity SharesSEBI:e73669fddfae055d83a422e4d1294515fa4a1b75
- 765,659 sharesEquity SharesSEBI:e0638e6e1f64d0d91d3c214da16fea7c32446711
- 7,500 shares@ ₹2,100.33335.1% of flowEquity SharesSEBI:2de85a1c8f69ba67370bd783bc213070da916959
- 17,500 shares@ ₹2,096.422712.0% of flowEquity SharesSEBI:2bb48c79b52656baee7520afd6448548702fa18e
- 40,000 shares@ ₹2,059.269127.3% of flowEquity SharesSEBI:cafc2196759a8fb553edbf15c936df29511a89da
- 25,000 shares@ ₹2,132.278917.5% of flowEquity SharesSEBI:dc04e3712864054e947be1024414ee4b9a198738
- 15,000 shares@ ₹2,005.374810.1% of flowEquity SharesSEBI:919b1dc6f90997580f5aecc3ebbdb37102dea332
- 10,000 shares@ ₹2,045.006.9% of flowEquity SharesSEBI:ed3a686ffff2fa8aca7e2000a9bd89a280449152
- 35,000 shares@ ₹1,767.284121.0% of flowEquity SharesSEBI:f2c307a4ce321dcacbc5972c0bb2fa45a1003f77
- 1,280,267 sharesEquity SharesSEBI:a5c50e587bf33c1c2b43acb7286b88b18bb700f7
- 1,280,267 sharesEquity SharesSEBI:ae3427f174368e39bfb2636a66b2f3a3717228fb
- 1,280,266 sharesEquity SharesSEBI:5ee44281e4e1e32a5f846054b191f10c90b12b2f
- 1,280,266 sharesEquity SharesSEBI:1dac5bef407c406b6fb8eb1e18ae75aaab3ee27c
- 2,405,840 sharesEquity SharesSEBI:2ebd9a550b0c1136641d5fb1584e16d2a395711a
- 2,405,840 sharesEquity SharesSEBI:df613f24b5c0269228c1d58e656d067682d22ce2
- 99,573 shares@ ₹1,980.4266.4% of flowEquity SharesSEBI:037c2ea378897b05e57a181a5080da511fb7448fCanonical exit: 22 May 2022 (T+90)
- 49,903 shares@ ₹2,000.4533.3% of flowEquity SharesSEBI:e55b070c5ff48f29dc04e701cf5333c760108c48Canonical exit: 19 May 2022 (T+90)
- 427 shares@ ₹1,974.7190.3% of flowEquity SharesSEBI:f58ef8025ad6606864b93eddcb99a7559b3dd3f1Canonical exit: 22 May 2022 (T+90)
- 97 shares@ ₹2,000.42270.1% of flowEquity SharesSEBI:88ba7bf33b2f52a65778bbd8ed17b2ec620e6afdCanonical exit: 19 May 2022 (T+90)
25 of 56 declarations
About Metropolis Healthcare Limited
Metropolis Healthcare Limited is a company specializing in medical diagnostic services in India. It offers a wide range of laboratory tests and health services.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
